Certain Restricted Stock Units of EyePoint Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 3-FEB-2024. These Restricted Stock Units will be under lockup for 60 days starting from 5-DEC-2023 to 3-FEB-2024.

Details:
Directors and executive officers, and Ocumension Therapeutics, one of significant shareholders (such persons, the ?lock-up parties?) have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each lock-up party, with limited exceptions, for a period of 60 days (or 30 days, in the case of Ocumension Therapeutics) after the date of this prospectus (such period, the ?restricted period?).